Pay in 4 interest-free payments of $24.00 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
BRD4770 also induces increased levels of lysine acetylation in cells without inhibiting histone deacetylases
12aR)-9-[2-(tert-butylamino)acetamido]-4
48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9
2019 Oct 30
Col III(αI)
Tideglusib Size:Solid 10 mg BRD4770 also induces increased levelsTideglusib, also known as NP031112, is a GSK 3 inhibitor, which is currently under clinical trial for Alzheimer's disease. Tideglusib protects neural stem cells against NMDA receptor overactivation. Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial. Tideglusib prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. Product information
US$ 49.00
US$ 40.45
US$ 214.07
US$ 18.95
US$ 25.00
US$ 214.07
US$ 306.00
US$ 117.00